News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shareholders Approve Merger Of AGT Biosciences (AGTGF) And ChemGenex Therapeutics, Inc. To Form ChemGenex Pharmaceuticals Limited



10/19/2005 5:08:47 PM

AGT Biosciences Limited (ASX:AGT) and ChemGenex Therapeutics, Inc. are pleased to announce that they have completed their merger transaction. The merger creates a genomics-driven global biotechnology company with two products in Phase II clinical development, and discovery and development capabilities in oncology, diabetes, obesity and depression.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES